| During follow-up of IPMN | Concurrent | Total |
---|---|---|---|
Colorectal cancer | 3 | 3 | 6 |
Gastric cancer | 1 | 0 | 1 |
Hepatocellular carcinoma | 1 | 1 | 2 |
Ovarian cancer | 0 | 1 | 1 |
Lung cancer | 1 | 1 | 2 |
Prostate cancer | 0 | 1 | 1 |
Endometrial cancer | 1 | 1 | 2 |
Esophageal cancer | 0 | 1 | 1 |
Breast cancer | 1 | 1 | 2 |
 | 8 | 10 | 18 |